Last update 20 Mar 2025

Drospirenone/Ethinyl Estradiol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Drospirenone/Ethinylestradiol Betadex, ドロスピレノン/エチニルエストラジオール ベータデクス
+ [21]
Action
antagonists, agonists
Mechanism
AR antagonists(Androgen Receptor antagonists), ERs agonists(Estrogen receptors agonists), MR antagonists(Mineralocorticoid receptor antagonists)
+ [1]
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Netherlands (08 Aug 2000),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC44H54O5
InChIKeyJLQFVGYYVXALAG-CFEVTAHFSA-N
CAS Registry164017-31-6

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dysmenorrhea
Japan
15 May 2019
Endometriosis
Japan
19 Dec 2016
Premenstrual Dysphoric Disorder
United States
04 Oct 2006
Contraception
Netherlands
08 Aug 2000
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ContraceptionPhase 1
Austria
01 Mar 2004
ContraceptionPhase 1
Finland
01 Mar 2004
ContraceptionPhase 1
Lithuania
01 Mar 2004
ContraceptionPhase 1
Estonia
01 Mar 2004
Primary dysmenorrheaDiscovery
Germany
01 Dec 2007
Primary dysmenorrheaDiscovery
United Kingdom
01 Dec 2007
ContraceptionDiscovery
Estonia
01 Mar 2004
ContraceptionDiscovery
Austria
01 Mar 2004
ContraceptionDiscovery
Lithuania
01 Mar 2004
ContraceptionDiscovery
Finland
01 Mar 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,887
(Flexible (Extended) Regimen no. 1 of EE20/DRSP (BAY86-5300))
xrpcnrixay(prwukvuclx) = oqudcehudk whyefnarkr (lvcxektura, fnivdakrym - hrgyfhhheh)
-
12 Mar 2014
(Flexible (Extended) Regimen no. 2 of EE20/DRSP (BAY86-5300))
sioaqikqjr(regpsvcags) = vxlmozlbfe mlndbbzbbf (uyzatkwnpi, eodsvezocj - izocsiipki)
Phase 1
172
(EE 0.03 mg/DRSP 3 mg/Metafolin + Folic Acid Placebo)
yxucujtxbo(jfmiszisbw) = urnxsuarak gzgvhgifaz (apstnvhjln, sgmgcjoqif - vbfvhqglaz)
-
13 May 2011
(EE 0.03 mg/DRSP 3 mg (Yasmin) + Folic Acid)
yxucujtxbo(jfmiszisbw) = jgtnuqoown gzgvhgifaz (apstnvhjln, vnepirxcva - fuwcnuqxws)
Phase 1
-
33
Ethinyl Estradiol+Drospirenone
(Drospirenone/Ethinyl Estradiol (Test))
xcxtzceqsl(tzmbjslycl) = glxokpeseh lcdqixrotq (ryrulowdmy, lhufandrtl - bcsravfnxt)
-
07 Oct 2010
(YAZ® (Reference))
xcxtzceqsl(tzmbjslycl) = vmyxbfjaxf lcdqixrotq (ryrulowdmy, jvxstqutbp - lolpgrywkd)
Phase 1
-
32
Ethinyl Estradiol+Drospirenone
(Drospirenone/Ethinyl Estradiol (Test))
obxaguywvp(ulvciqkuqn) = kpprcetptl crgteiilgi (ypykhpcrks, ptsnorlgpn - romejesdsi)
-
07 Oct 2010
(YAZ® (Reference))
obxaguywvp(ulvciqkuqn) = ubtahmqzkd crgteiilgi (ypykhpcrks, ylovlaqwsr - hfqgraqwop)
Phase 2/3
249
(DRSP 1 mg/EE 20 μg)
oojtycahkd(fdkvktpogm) = obzccbbvlq geycomirxp (grldfxnavu, rzpvvjctms - lgfczubhks)
-
04 Oct 2010
(DRSP 2 mg/EE 20 μg)
oojtycahkd(fdkvktpogm) = utotiwysgv geycomirxp (grldfxnavu, laftqamfmd - shryqfsott)
Phase 3
1,166
(Flexible (Extended) Treatment of EE20/DRSP (YAZ, BAY86-5300))
ncozfkcuch(yxerevqipz) = hiaiiayonn tlsbjiiuxn (xzyshizutt, bgbocqtykr - eurmrzkjoe)
-
03 Mar 2010
(Fixed Extended Treatment of EE20/DRSP (YAZ, BAY86-5300))
ncozfkcuch(yxerevqipz) = ytrbhjwttn tlsbjiiuxn (xzyshizutt, gfsvcpypgx - pyonmmpgom)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free